Trustar Capital acquires Chinese throat medicine maker Guilong Pharmaceutical
Trustar Capital, the private equity (PE) arm of Chinese alternative investment firm CITIC Capital Holdings, has wrapped up its acquisition ...
Read moreTrustar Capital, the private equity (PE) arm of Chinese alternative investment firm CITIC Capital Holdings, has wrapped up its acquisition ...
Read moreCarlyle Group Inc and Trustar Capital are planning to raise $4 billion from wealth funds to buy part of their ...
Read more© 2023 earth-news.info